Company
Graybug Vision, Inc.
Also known as Graybug Vision
- Status
- IPOas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Graybug Vision, Inc. was a clinical-stage ophthalmology company developing sustained-release therapies. IPO in September 2020 (NASDAQ: GRAY).
About the company
- Status notes
- IPO in September 2020 (NASDAQ: GRAY)
Loading relationship preview